Neuropeptides in Research: Selank, Semax, Epithalon & DSIP
A research reference on neuropeptide tools — covering Selank's GABAergic mechanisms, Semax's BDNF upregulation, Epithalon's telomerase activity, and DSIP's role in sleep architecture and HPA axis modulation.
Neuropeptides as Research Tools
Neuropeptides are short amino acid chains that act as signaling molecules in the central and peripheral nervous systems, modulating neurotransmitter release, synaptic plasticity, and neuroendocrine function. Unlike classical neurotransmitters such as glutamate or GABA, neuropeptides are typically synthesized in the cell body, packaged into large dense-core vesicles, and released from axon terminals or dendrites in response to high-frequency neuronal firing. They act on G protein-coupled receptors and produce effects that are generally slower in onset but longer in duration than classical neurotransmitter signaling.
As a compound class, neuropeptides have attracted growing research interest for their roles in anxiety regulation, cognitive performance, sleep architecture, and neuroprotection — areas where conventional small-molecule pharmacology has historically struggled to produce clean, selective tools. The synthetic neuropeptide analogs available for research use offer investigators the ability to study specific neuropeptide receptor pathways with greater selectivity and stability than endogenous peptides, which are typically rapidly degraded by peptidases in biological systems.
Selank: GABAergic Modulation & Anxiolytic Research
Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) analog of the endogenous immunomodulatory tetrapeptide tuftsin (Thr-Lys-Pro-Arg). The three additional C-terminal amino acids (Pro-Gly-Pro) were added to improve metabolic stability and extend the biological half-life of the compound in research systems. Selank has been studied extensively in preclinical models for its anxiolytic-like effects, which appear to be mediated through modulation of GABAergic tone and serotonin metabolism rather than direct benzodiazepine receptor binding.
This mechanistic distinction makes Selank a valuable research tool for investigators studying anxiety pathways without the confounding receptor promiscuity of classical anxiolytics. Benzodiazepines act directly on GABA-A receptor allosteric sites, producing broad CNS depression alongside anxiolysis. Selank's apparent ability to modulate anxiety-related behavior through indirect GABAergic mechanisms — potentially involving enkephalin metabolism and serotonin turnover — offers a mechanistically distinct research approach for studying anxiety neurobiology.
Research has also explored Selank's immunomodulatory properties, consistent with its structural relationship to tuftsin, which is known to activate macrophages and natural killer cells. Studies have investigated Selank's effects on cytokine expression, T-cell activity, and the relationship between immune function and anxiety-related behavior — an area of growing interest in psychoneuroimmunology research.
Semax: BDNF Upregulation & Neuroprotection
Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) analog of the ACTH(4-7) fragment (Met-Glu-His-Phe), with the addition of a Pro-Gly-Pro C-terminal sequence for metabolic stability. ACTH(4-7) is the minimal active fragment of adrenocorticotropic hormone responsible for its neurotrophic and neuroprotective effects, independent of its adrenal steroidogenic activity. Semax retains these neurotrophic properties without the hormonal effects of full-length ACTH.
The most studied mechanism of Semax in research models is its ability to upregulate brain-derived neurotrophic factor (BDNF) expression. BDNF is a member of the neurotrophin family that promotes neuronal survival, synaptic plasticity, and long-term potentiation — processes central to learning, memory, and neuroprotection. Research has demonstrated that Semax increases BDNF mRNA and protein levels in the hippocampus and frontal cortex of rodent models, making it a useful tool for studying BDNF-dependent neuroplasticity mechanisms.
Semax has also been studied for its effects on dopaminergic and serotonergic neurotransmission, with research suggesting modulation of dopamine receptor sensitivity and serotonin turnover in limbic brain regions. These effects have been investigated in models of cognitive performance, attention, and stress resilience, positioning Semax as a research tool for studying the intersection of neurotrophic factor signaling and monoamine neurotransmitter systems.
Epithalon: Telomerase Activity & Cellular Aging Research
Epithalon (Epitalon) is a synthetic tetrapeptide — Ala-Glu-Asp-Gly — derived from the pineal gland peptide epithalamin. It was originally identified through research into the role of the pineal gland in aging and neuroendocrine regulation. Research interest in Epithalon centers on its apparent ability to stimulate telomerase activity and elongate telomeres in somatic cells, making it a frequently used tool in longevity and cellular aging research.
Telomeres are repetitive DNA sequences (TTAGGG in humans) that cap the ends of chromosomes and protect them from degradation and end-to-end fusion. With each cell division, telomeres shorten due to the end-replication problem, eventually reaching a critical length that triggers cellular senescence or apoptosis. Telomerase is the enzyme responsible for maintaining telomere length by adding telomeric repeats to chromosome ends, but its expression is suppressed in most somatic cells after development. Research using Epithalon investigates whether the peptide can reactivate telomerase expression in somatic cells and whether this reactivation affects cellular lifespan and senescence markers.
Beyond telomere biology, Epithalon has been studied for its effects on melatonin secretion, antioxidant enzyme expression, and circadian rhythm regulation — consistent with its pineal gland origin. Research has explored its effects on superoxide dismutase and catalase activity, and its potential role in modulating the age-related decline in pineal melatonin production.
DSIP: Sleep Architecture & HPA Axis Research
Delta sleep-inducing peptide (DSIP) is a nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) originally isolated from rabbit cerebral venous blood during slow-wave (delta) sleep. It was first characterized in 1977 and has since been studied for its role in sleep regulation, stress response modulation, and hypothalamic-pituitary axis function. DSIP is found in the hypothalamus, limbic system, pituitary, and peripheral tissues, suggesting a broad physiological role beyond sleep regulation.
Research using DSIP has focused on its effects on sleep architecture — specifically its apparent ability to increase the proportion of slow-wave sleep (SWS) and reduce sleep latency in animal models. The mechanisms underlying these effects are not fully characterized, but research has implicated interactions with the somatostatin system, opioid receptors, and the HPA axis. DSIP appears to modulate corticotropin-releasing hormone (CRH) secretion and ACTH release, suggesting a role in the stress-sleep interface that is of particular interest in psychoneuroendocrinology research.
Research Use Disclaimer
All compounds described are sold by Aldera Bio Labs strictly for in-vitro laboratory research by qualified professionals. Not for human or animal consumption. Not FDA-approved. Must be 21+ to purchase.